CCLD

EX-99.1

2 ex99-1.htm

EX-99.1

Exhibit 99.1

CareCloud Reports Second Quarter 2026 Results

Revenue Grows 16%; Ninth Consecutive Quarter of Positive GAAP Net Income

SOMERSET,

N.J., August 6, 2026 (GLOBE NEWSWIRE)—CareCloud, Inc. (Nasdaq: CCLD), a leader in AI-powered healthcare technology and revenue cycle management solutions for medical practices and health systems nationwide, today announced financial results for the quarter ended June 30, 2026 and reaffirmed its full-year guidance.

Second Quarter 2026 Financial Highlights:

●Revenue of $31.9 million, compared to $27.4 million in Q2 2025

●GAAP

net income of $1.1 million, compared to $2.9 million in Q2 2025

●GAAP

EPS of $0.00 per share, compared to $0.04 per share in Q2 2025

●Adjusted EBITDA of $5.9 million, compared to $6.5 million in Q2 2025

Year-to-date

2026 Highlights:

●Revenue of $63.2 million, compared to $55.0 million in the same period last year

●GAAP

net income of $2.0 million, compared to $4.9 million in the same period last year

●GAAP

EPS of ($0.01) per share, compared to $0.02 per share in the same period last year

●Adjusted EBITDA of $11.3 million, compared to $12.1 million in the same period last year

Key Second Quarter Accomplishments:

●Compliance and Audit-Defense Market Entry: Expanded the product portfolio through the acquisition of Empower Healthcare & Compliance Partners, opening a new growth opportunity by bringing trusted compliance, audit-defense, and regulatory expertise to CareCloud’s network of more than 40,000 providers.

●Full Redemption of Series B Preferred Stock: Completed the redemption of all outstanding Series B Preferred Stock on May 15, 2026.

●Sustained Profitability: Delivered the ninth consecutive quarter of positive GAAP net income.

Management Commentary

“This quarter we grew revenue 16%, delivered our ninth consecutive quarter of positive GAAP net income, and entered the compliance and audit-defense market through our acquisition of Empower Healthcare. We’re investing deliberately in what we believe defines our next phase of growth — our AI solutions, our expanding capabilities, and the cross-sell opportunity across our more than 40,000 providers.” — Stephen Snyder, Chief Executive Officer, CareCloud

“Our AI and acquisition strategies have become a single, unified growth engine. Every platform we bring into CareCloud becomes smarter, faster, and more valuable when we layer in our AI capabilities. We are still in the early innings of unlocking the cross-sell potential across our expanded client base, and we are increasingly seeing customers adopt our AI-enabled offerings.” — A. Hadi Chaudhry, Chief Strategy Officer, CareCloud

“As expected, profitability this quarter reflects deliberate investments we are making today — increased R&D spending on our AI-enabled capabilities and increased interest expense from simplifying our capital structure through the Series B redemption — that we believe will deliver returns over time. We expect these investments to enhance scalability, improve operational efficiency, and support long-term margin expansion.” — Norman Roth, Interim Chief Financial Officer and Corporate Controller, CareCloud

1

2026 Outlook

The Company is reaffirming its guidance for calendar year 2026.

For the Fiscal Year Ending December 31, 2026 Full Year 2026 Guidance

Revenue $128 – $132 million

Adjusted EBITDA $29 – $31 million

GAAP Net Income Per Share (EPS) $0.20 – $0.23

Our expectations regarding future profitability, including adjusted EBITDA and earnings-per-share guidance, are based on management’s current beliefs and assumptions regarding, among other things, the signing and continuation of certain client and vendor relationships, the anticipated timing and scope of client projects, and our timely execution of integration and expense-management initiatives intended to align our cost structure with those objectives.

Conference Call Information

CareCloud management will host a live conference call today, August 6, 2026, at 8:30 a.m. Eastern Time to discuss second quarter 2026 results and the Company’s 2026 strategy.

Webcast: ir.carecloud.com/events

Dial-in

(Audio Only): 201-389-0920 | Reference: “CareCloud, Inc. Second Quarter 2026 Results Conference Call.”

Replay Dial-in: 412-317-6671 | Access Code: 13761329 (available approximately 3 hours after the call).

About CareCloud

CareCloud brings disciplined innovation to the business of healthcare. Our suite of AI and technology-enabled solutions helps clients increase financial and operational performance, streamline clinical workflows and improve the patient experience. More than 40,000 providers count on CareCloud to help them improve patient care, while reducing administrative burdens and operating costs. Learn more about our products and services, including revenue cycle management (RCM), practice management (PM), electronic health records (EHR), business intelligence, patient experience management (PXM) and digital health, at c

EX-99.1

2 ex99-1.htm

EX-99.1

Exhibit 99.1

NASDAQ:

CCLD | CCLDO

CareCloud Reports Q1 2026 Results

Reaffirms Guidance Following Capital Structure Simplification; Revenue Grows 13% Year-Over-Year

SOMERSET,

N.J., May 7, 2026 (GLOBE NEWSWIRE)—CareCloud, Inc. (Nasdaq: CCLD, CCLDO) (“CareCloud” or the “Company”), a leader in AI-powered healthcare technology and revenue cycle management solutions for medical practices and health systems nationwide, today announced financial results for the quarter ended March 31, 2026. The Company reaffirmed its previously issued financial guidance following the successful closing of a $50 million credit facility, the announced redemption of 100% of its Series B Preferred Stock, and AI product launches. Together, these milestones mark a pivotal step in CareCloud’s ongoing growth trajectory—positioning the Company to scale its AI-driven revenue and expand margins, reporting its eighth consecutive quarter of positive GAAP net income with a meaningfully simpler capital structure for the future.

First Quarter 2026 Financial Highlights:

●Revenue of $31.3 million, compared to $27.6 million in Q1 2025

●GAAP

net income of $922,000, compared to a net income of $1.9 million in Q1 2025

●Adjusted EBITDA of $5.4 million, compared to $5.6 million in Q1 2025

●GAAP

EPS of ($0.01), compared to ($0.04) per share in Q1 2025

Recent Accomplishments

●Full Scheduled Redemption of Series B Preferred Stock: Redemption scheduled for May 15, 2026

●Inpatient Software Market Entry: Expanded product portfolio includes inpatient EHR, RCM and analytics. #1 Black Book ranked EDIS platform— significantly broadening the total addressable market

●AI Center of Excellence Live: Launched stratusAI Desk Agent (~75% of inbound calls automated) and stratusAI Voice Audit

Management Commentary

“Q1 2026 marks the start of an exciting new chapter for CareCloud. We delivered 13% year-over-year revenue growth, expanded our AI offering and our addressable market into the inpatient segment, and took decisive action to simplify our capital structure with the announced full redemption of our Series B Preferred Stock and the closing of a new $50 million credit facility. With the Medsphere integration substantially complete, a stronger balance sheet, and our 2026 guidance reaffirmed, we believe CareCloud is uniquely positioned to translate this momentum into accelerating, durable shareholder value through the balance of 2026 and beyond.”

— Stephen Snyder, Chief Executive Officer, CareCloud

“This was the quarter our AI strategy moved from promise to performance. stratusAI Desk Agent is now resolving approximately 75% of inbound patient calls autonomously, stratusAI Voice Audit is surfacing revenue and compliance opportunities in real time, and our newly launched AI Center of Excellence is shipping new agentic capabilities at an accelerating pace. By layering these AI services on top of our expanded ambulatory and inpatient platform—including our #1 Black Book–ranked EDIS—we are building a differentiated, full-stack healthcare technology offering that scales with every customer we serve and creates a durable, technology-led competitive advantage.”

1

— A. Hadi Chaudhry, Chief Strategy Officer, CareCloud

“We are reaffirming our 2026 guidance based on our confidence for the year. The integration of our Medsphere acquisition impacted our earnings as anticipated this quarter and is now substantially complete, positioning us to deliver improving margins through the balance of 2026. We look forward to redeeming all of our Series B Preferred Stock for cash on May 15.”

— Norman Roth, Interim Chief Financial Officer and Corporate Controller, CareCloud

2026 Outlook

CareCloud entered 2026 with significant operating momentum and is reaffirming its guidance for calendar year 2026.

For the Fiscal Year Ending December 31, 2026

Full Year 2026 Guidance

Revenue $128 – $132 million

Adjusted

EBITDA

$29 – $31 million

GAAP

Net Income Per Share (EPS) $0.20 – $0.23

Revenue guidance is based on management’s expectations for contributions from existing clients, together with cross-selling and other organic and inorganic growth. EPS guidance of $0.20–$0.23 represents a 100-130% increase from the $0.10 achieved in full year 2025. Adjusted EBITDA guidance is $29–$31 million compared to the 2025 amount of $27.5 million.

As anticipated, Q1 2026 GAAP net income reflects a temporary, near-term impact from elevated amortization of acquired intangible assets and one-time integration costs tied to the Medsphere acquisition (which closed August 2025) and our other 2025 acquisitions. Q1 2026 adjusted EBITDA was depressed due to transition costs from Medsphere which have largely been eliminated by the end of Q1, so they will have a decreasing impact in future quarters. These items are non-recurring and integration-related, are expected to subside as the integrations are completed, and are not indicative of the underlying earnings power of the bu